Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ceftriaxone in ALS
NCT00349622Phase 3Completed
- Sponsor
- Massachusetts General Hospital
- Start
- Jul 2006
- Primary completion
- Nov 2012
- Modality
- Reversible Covalent Inhibitors
- Countries
- 2
01
Overview
A Phase 3 trial of ceftriaxone in amyotrophic lateral sclerosis (ALS), sponsored by Massachusetts General Hospital. Started Jul 2006; status: completed.
02
Drugs
ceftriaxone
03
Conditions
amyotrophic lateral sclerosis (ALS)
Beyond the preview
Go deeper on NCT00349622.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00349622.